SC 13G

Company

Spyre Therapeutics, Inc.

Filed

December 8, 2017

Accession Number

0001144204-17-062996

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →